All Stories

  1. Gamma delta+ intraepithelial lymphocytes and coeliac lymphogram in a diagnostic approach to coeliac disease in patients with seronegative villous atrophy
  2. Systematic Review and Meta-Analysis: Accuracy of Both Gamma Delta+ Intraepithelial Lymphocytes and Coeliac Lymphogram Evaluated by Flow Cytometry for Coeliac Disease Diagnosis
  3. Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study)
  4. A Scoring System for Identifying Patients Likely to Be Diagnosed with Low-Grade Coeliac Enteropathy
  5. Systematic review with meta-analysis: the prevalence of bile acid malabsorption and response to colestyramine in patients with chronic watery diarrhoea and previous cholecystectomy
  6. Post-Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry
  7. Study of the standard direct costs of various techniques of advanced endoscopy. Comparison with surgical alternatives
  8. Case-finding of coeliac disease by using a POCT
  9. Recommendations to report and interpret HLA genetic findings in coeliac disease
  10. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study
  11. Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment
  12. Letter: the definition of budesonide dependence in microscopic colitis
  13. Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
  14. Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
  15. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives
  16. Escasa eficacia de metronidazol en la erradicación de Blastocystis hominis en pacientes sintomáticos: serie de casos y revisión sistemática de la literatura
  17. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia
  18. Systematic Review and Meta-analysis Show 3% of Patients With Celiac Disease in Spain to be Negative for HLA-DQ2.5 and HLA-DQ8
  19. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients
  20. Colitis microscópica: avances para una mejor identificación en los pacientes con diarrea crónica
  21. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients
  22. Diarrea crónica: definición, clasificación y diagnóstico
  23. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
  24. Double-Blind Randomized Clinical Trial: Gluten versus Placebo Rechallenge in Patients with Lymphocytic Enteritis and Suspected Celiac Disease
  25. Letter: oral low-dose methotrexate for collagenous colitis - authors’ reply
  26. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases
  27. Immunological Differences between Lymphocytic and Collagenous Colitis
  28. Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study
  29. The low-FODMAP diet for irritable bowel syndrome: Lights and shadows
  30. Prevalence and Natural History of Microscopic Colitis: A Population-Based Study With Long-term Clinical Follow-up in Terrassa, Spain
  31. Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group
  32. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer
  33. Endoscopic surveillance in patients with multiple (10–100) colorectal polyps
  34. Grado de adecuación de las indicaciones de la colonoscopia en una unidad de acceso abierto
  35. Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea
  36. Systematic review: noncoeliac gluten sensitivity
  37. Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3)
  38. Accuracy of GastroPanel for the diagnosis of atrophic gastritis
  39. Intestinal Intraepithelial Lymphocyte Cytometric Pattern Is More Accurate than Subepithelial Deposits of Anti-Tissue Transglutaminase IgA for the Diagnosis of Celiac Disease in Lymphocytic Enteritis
  40. Letter: persisting clinical symptoms in microscopic colitis in remission
  41. Sensibilidad al gluten no celiaca: una revisión crítica de la evidencia actual
  42. Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis
  43. Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype
  44. Prevalence and Characteristics ofMUTYH-Associated Polyposis in Patients with Multiple Adenomatous and Serrated Polyps
  45. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) survey, a specific questionnaire to measure quality of life in patients with celiac disease
  46. Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility
  47. Clinical Subtypes and Molecular Characteristics of Serrated Polyposis Syndrome
  48. Impact of Current Smoking on the Clinical Course of Microscopic Colitis
  49. Genetic susceptibility variants associated with colorectal cancer prognosis
  50. Letter: mucosal healing and mortality in coeliac disease
  51. Comparison of lymphocyte isolation methods for endoscopic biopsy specimens from the colonic mucosa
  52. Lymphocytic Enteropathy, HLA-DQ2/DQ8 Genotype and Wheat-Dependent Symptoms: Non-Celiac Wheat Sensitivity or Marsh I Celiac Disease?
  53. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis
  54. Letter: the role of stent in the treatment of Crohn's disease strictures - authors’ reply
  55. Helicobacter pyloriinfection as a cause of iron deficiency anaemia of unknown origin
  56. BMP2 / BMP4 colorectal cancer susceptibility loci in northern and southern European populations
  57. Comment to “High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of coeliac disease”
  58. Microscopic colitis: Current status, present and future challenges
  59. Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease
  60. Is a gluten-free diet necessary in Marsh I intestinal lesions in patients with HLADQ2, DQ8 genotype and without gastrointestinal symptoms?
  61. Reliability of symptom analysis during carbohydrate hydrogen-breath tests
  62. Letter: are lymphocytic colitis and collagenous colitis really the same disease?
  63. Lymphocytic duodenosis: Aetiology and long-term response to specific treatment
  64. Prevalence and clinical relevance of enteropathy associated with systemic autoimmune diseases
  65. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
  66. Enteropatía sensible al gluten y dispepsia funcional
  67. Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience
  68. Susceptibility genetic variants associated with early-onset colorectal cancer
  69. Efficacy of anti-TNF therapies in refractory severe microscopic colitis
  70. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins
  71. Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohnʼs disease
  72. Mild enteropathy as a cause of iron-deficiency anaemia of previously unknown origin
  73. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: A population-based study
  74. Reply
  75. The prevalence of coeliac disease is significantly higher in children compared with adults
  76. Susceptibility Genetic Variants Associated With Colorectal Cancer Risk Correlate With Cancer Phenotype
  77. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
  78. Características de los pacientes con poliposis adenomatosa familiar en España. Resultados iniciales del Registro Español de Poliposis Adenomatosa Familiar
  79. Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer
  80. Fructose-sorbitol malabsorption
  81. Paucicellular Lymphocytic Colitis: Is It a Minor Form of Lymphocytic Colitis? A Clinical Pathological and Immunological Study
  82. ¿Existe la diarrea funcional? ¿Qué pruebas hay que realizar para llegar a otros diagnósticos?
  83. A short review of malabsorption and anemia
  84. Impact of mass screening for gluten-sensitive enteropathy in working population
  85. Lack of Clinical Usefulness of Das-1 Monoclonal Antibody and Mucin Expression as Risk Markers of Gastric Carcinoma in Patients With Gastric Intestinal Metaplasia
  86. How Do We Manage Vaccinations in Patients with Inflammatory Bowel Disease?
  87. Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study
  88. Pitfalls and errors in the diagnosis of collagenous and lymphocytic colitis
  89. Diagnostic value of duodenal antitissue transglutaminase antibodies in gluten-sensitive enteropathy
  90. Systematic Evaluation of the Causes of Chronic Watery Diarrhea With Functional Characteristics
  91. Detection of Metachronous Neoplasms in Colorectal Cancer Patients: Identification of Risk Factors
  92. Epidemiology of microscopic colitis * Authors' response
  93. How much symptom overlap is there between microscopic colitis and IBS?
  94. Drug Consumption and the Risk of Microscopic Colitis
  95. Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis
  96. Sugar malabsorption in functional abdominal bloating: A pilot study on the long-term effect of dietary treatment
  97. Intestinal spirochetosis and chronic watery diarrhea: Clinical and histological response to treatment and long-term follow up
  98. Nutritional care of the patient with constipation
  99. Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis
  100. Cribado de la enfermedad celíaca en grupos de riesgo
  101. Subepithelial myofibroblasts and tenascin expression in microscopic colitis
  102. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up
  103. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes
  104. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial
  105. Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status
  106. Effect of L-arginine on the course of experimental colitis
  107. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
  108. Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check-up
  109. Reply
  110. Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.
  111. Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis.
  112. Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence.
  113. How Effective Is Enteral Nutrition in Inducing Clinical Remission in Active Crohn's Disease? A Meta-Analysis of the Randomized Clinical Trials
  114. Determinants of plasma fatty acid abnormalities in patients with active inflammatory bowel disease: A multivariate analysis
  115. Magnesium hydrogen breath test using end expiratory sampling to assess achlorhydria in pernicious anaemia patients.
  116. Accuracy of breath H2 criteria to detect carbohydrate malabsorbtion
  117. Enteral nutrition as primary therapy in Crohn's disease.
  118. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.
  119. Reply
  120. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.
  121. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
  122. Plasma Polyunsaturated Fatty Acids in Liver Cirrhosis With or Without Chronic Hepatic Encephalopathy: A Preliminary Study
  123. Liver Function Tests Abnormalities in Patients with Inflammatory Bowel Disease Receiving Artificial Nutrition: A Prospective Randomized Study of Total Enteral Nutrition vs Total Parenteral Nutrition